Relese-20

A Selective Barrier Designed to Provide Protection for Acute and Chronic Wounds

Relese is a fenestrated dehydrated complete human placental membrane (dCHPM) allograft. Fenestration of the allograft creates a selective barrier that protects the wound from the surrounding environment while allowing wound exudate to drain. Through the patented Clearify® technology, all three layers of the native placental membrane (amnion, intermediate layer, and chorion) and key structural proteins and components are retained.1

Never delaminated
Easy to handle and apply
4x thicker than the competitor graft1,2
Higher concentration of hyaluronic acid than the competitor allograft1,2

Common Clinical Applications

Wound Types*

Acute and chronic wounds such as:

  • Dermatologic Wounds
  • Diabetic Ulcers
  • Pressure Ulcers
  • Surgical Wounds
  • Traumatic Wounds
  • Venous Ulcers
*Relese is intended to be used as a selective barrier.
Specialties

Commonly used in specialties such as:

  • Dermatology
  • General Surgery
  • Orthopedic Surgery
  • Plastic Surgery
  • Podiatry
  • Vascular Surgery

Common Anatomical Applications

Sizes & SKUs

Size 2 x 3 cm 4 x 4 cm 6 x 8 cm
SKU RL-2030 RL-4040 RL-6080

Sheet Format  |  Shelf-stable for up to five (5) years

Related Resources

  1. Data on file.
  2. Data is compared to the leading dual-layer allograft and reported as an average.
  3. Manna B, Cooper JS. Radiation Therapy-Induced Skin Ulcer. [Updated 2023 Apr 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.
  4. Sano, M., Yamamoto, K., Seo, A., Akai, A., Akagi, D., Takayama, T., & Hoshina, K. (2019). Wound healing after revascularization for critical limb ischemia. International angiology : a journal of the International Union of Angiology, 38(3), 225–229. https://doi.org/10.23736/S0392-9590.19.04096-3
  5. Hingorani, A., LaMuraglia, G. M., Henke, P., Meissner, M. H., Loretz, L., Zinszer, K. M., Driver, V. R., Frykberg, R., Carman, T. L., Marston, W., Mills, J. L., Sr, & Murad, M. H. (2016). The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of vascular surgery, 63(2 Suppl), 3S–21S. https://doi.org/10.1016/j.jvs.2015.10.003

Patents: www.stimlabs.com/patents

 

logos_StimLabs_web

© 2016-2024 Stimlabs® LLC; STIMLABS, REVITA, COGENEX, ENVERSE, VIALIZE, RELESE, and CLEARIFY are registered trademarks of Stimlabs LLC. 

Join our mailing list

This field is for validation purposes and should be left unchanged.